<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04748133</url>
  </required_header>
  <id_info>
    <org_study_id>6658</org_study_id>
    <nct_id>NCT04748133</nct_id>
  </id_info>
  <brief_title>Acupuncture for Recovery and Postoperative Nausea and Vomiting After Middle Ear Surgeries</brief_title>
  <official_title>Acupuncture for Enhancing Recovery and Attenuating Postoperative Nausea and Vomiting After Middle Ear Surgeries: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Modern surgery management needs increasing operating room turnover and more ambulatory&#xD;
      surgery. In order to come over this challenge, the recovery needs to be optimized. Enhancing&#xD;
      recovery could be achieved by preventing postoperative pain and postoperative nausea and&#xD;
      vomiting. Middle ear surgery is a common ambulatory surgery with increasing occurrence of&#xD;
      postoperative nausea and vomiting.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sample size: as percent of vomiting following acupuncture and following standard anesthesia&#xD;
      is 0.13% and 29.2% respectively so sample size is 58 (29 in each group). Sample is calculated&#xD;
      using open epi program with confidence level 95% and power 80%.&#xD;
&#xD;
      Patients in Group C (control group) (n=29): will receive no treatment. While patients in&#xD;
      Group A (Acupuncture group) (n=29): will receive needle acupuncture.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 20, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of postoperative nausea and vomiting</measure>
    <time_frame>up to 24 hours postoperative</time_frame>
    <description>Postoperative nausea and vomiting impact scale score . Questions Answers score Did you have vomiting or dry retching? No 0 Once 1 Twice 2 Three or more times 3&#xD;
Have you experienced a feeling of nausea? If yes, has it interfered with your daily activities? Not at all 0 Sometimes 1 Often/most of the times 2 All the time 3&#xD;
Summation of numerical answer to question 1 plus 2 equal the PONV impact scale. PONV Impact Scale Score of ≥5 represents clinically important PONV</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>extubation time</measure>
    <time_frame>up to 10 minutes postoperative</time_frame>
    <description>time from discontinuation of isoflurane to extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recovery time</measure>
    <time_frame>up to 30 minutes postoperative</time_frame>
    <description>time from discontinuation of isoflurane to first response to verbal command</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time of discharge</measure>
    <time_frame>up to 30 minutes postoperative</time_frame>
    <description>The time from arrival to PACU to discharge to the ward) according to Modified Aldert score Modified Aldert score . Assessment item Condition Grade Activity, able to move, voluntarily or on command 4 extremities 2 2 extremities 1 No 0&#xD;
Breathing Able to breathe deeply &amp; cough freely 2 Dyspnea, shallow or limited breathing 1 Apnea 0 Consciousness Fully awake 2 Arousable on calling 1 Unresponsive 0&#xD;
Circulation (blood pressure) ±20% of pre-anesthesia level 2&#xD;
20% to 49% of pre-anesthesia level 1&#xD;
50% of pre-anesthesia level 0 SPO2 Maintain SPO2 &gt;92% in ambient air 2 Maintain SPO2 &gt;90% with O2 1 Maintain SPO2 &lt;90% with O2 0&#xD;
Patient having a score of 9 or higher is discharged</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total number of rescue antiemetic (metoclopramide)</measure>
    <time_frame>in the first 24 hour postoperative</time_frame>
    <description>Any patient will receive 10 mg intravenous metoclopramide immediately if there is nausea and vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain</measure>
    <time_frame>up to 30 minutes, 2 hours and 4 hours postoperative</time_frame>
    <description>Visual Analogue Scale (VAS) . A commonly used scale is a 10-cm line labeled with &quot;worst pain imaginable&quot; on the right border and &quot;no pain&quot; on the left border. The patient is instructed to make a mark along the line to represent the intensity of pain currently being experienced. IV paracetamol 1 gm every 6hs as a protocol for pain management and IV pethidine 30 mg as rescue analgesic will be given if VAS ≥ 4. Total doses and number of analgesics will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of participant with side effects of acupuncture</measure>
    <time_frame>up to 24 hours postoperative</time_frame>
    <description>bleeding, soreness, or bruising at the site of needle insertion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">59</enrollment>
  <condition>Treatment Complication</condition>
  <arm_group>
    <arm_group_label>acupuncture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the acupuncture group will receive a standardised treatment with 12 needles (sharp tip, stainless steel needles, size 0.3 X 40 mm) at 7 acupuncture points Du 26 and Ren 17 (on the middle body line), and bilateral LI 4, HE 7, LV 3, ST 36 and PC 6). Application of the needles is performed by a licensed medical acupuncturist.&#xD;
The needles will be inserted after endotracheal intubation and mechanical ventilation and will be removed immediately before patient extubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>no treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acupuncture needles</intervention_name>
    <description>Site of acupuncture points:&#xD;
Du 26: At junction of the upper and middle third of philtrum.&#xD;
Ren 17: On the midline level with the 4th intercostal space midway between the nipples.&#xD;
LI4 (Large Intestine 4): On the dorsum of the hand, between the 1st and 2nd metacarpal bones&#xD;
HT7 (Heart 7): On the ulnar end of the transverse crease of the wrist, in the small depression between the pisiform and ulna bones&#xD;
LV3 (Liver 3): On dorsum of the foot in a depression distal to the junction of the 1st and 2nd metatarsal bones.&#xD;
ST36 (Stomach 36): Antero-lateral leg, 1 middle-finger breadth next to the anterior crest of tibia, 3 cun under the depression lateral to the patellar ligament.&#xD;
PC6 (Pericardium 6): Palmar aspect of the forearm, between the tendons, 2 cun away from the transverse crease of the wrist</description>
    <arm_group_label>acupuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>no treatment</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Written informed consent from the patient.&#xD;
&#xD;
          -  Age: 21-60 years old.&#xD;
&#xD;
          -  Sex: both sex (males or females).&#xD;
&#xD;
          -  Physical status: ASA 1&amp; II.&#xD;
&#xD;
          -  BMI = (20-30 kg/m2).&#xD;
&#xD;
          -  Type of operations: elective unilateral middle ear surgeries such as tempanoplasty,&#xD;
             stapedectomy and mastedictomy.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Altered mental state&#xD;
&#xD;
          -  Patients with Drug abuse or alcohol.&#xD;
&#xD;
          -  Patients with on antipsychotic drugs, regular antiemetic therapy or receiving&#xD;
             antiemetic 24 hour before surgery.&#xD;
&#xD;
          -  Patients with pre-treatment with acupuncture or trigger point injection.&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marwa Zakzouk, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marwa Zakzouk, MD</last_name>
    <phone>01004178761</phone>
    <phone_ext>002</phone_ext>
    <email>dr.marwa.zu@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Al shaimaa Kamel, MD</last_name>
    <phone>01005593169</phone>
    <phone_ext>002</phone_ext>
    <email>AlshaimaaKamel80@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marwa Zakzouk, MD</last_name>
      <phone>01004178761</phone>
      <phone_ext>002</phone_ext>
      <email>dr.marwa.zu@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Alshaimaa Kamel</last_name>
      <phone>01005593169</phone>
      <email>Alshaimaakamel80@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2021</study_first_posted>
  <last_update_submitted>February 22, 2021</last_update_submitted>
  <last_update_submitted_qc>February 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Marwa Mahmoud Abd Allah Zakzouk</investigator_full_name>
    <investigator_title>Lecturer of Anesthesia &amp; Surgical Intensive Care, Zagazig University</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

